Vasculitis as Temporally Associated With COVID-19 Infection or Vaccination: A Single-center Experience

REFERENCES

1. 1.↵
   1. Ramos-Casals M,
   2. Brito-Zerón P,
   3. Mariette X.

   Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315–32.

   OpenUrl
2. 2.↵
   1. Lang TF,
   2. Eber RM,
   3. Reddy MS.

   Vaccines for COVID-19: an overview. Compend Contin Educ Dent 2021;42:298–304.

   OpenUrl
3. 3.↵
   1. Rasmussen C,
   2. Tisseyre M,
   3. Garon-Czmil J, et al

   . Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev 2021;20:102707.

   OpenUrl
4. 4.↵
   1. Bonetto C,
   2. Trotta F,
   3. Felicetti P, et al; Brighton Collaboration Vasculitis Working Group

   . Vasculitis as an adverse event following immunization – systematic literature review. Vaccine 2016; 34:6641–51.

   OpenUrlCrossRef
5. 5.↵
   1. Cohen SR,
   2. Prussick L,
   3. Kahn JS,
   4. Gao DX,
   5. Radfar A,
   6. Rosmarin D.

   Leukocytoclastic vasculitis flare following the COVID-19 vaccine. Int J Dermatol 2021;60:1032–3.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Sekar A,
   2. Campbell R,
   3. Tabbara J,
   4. Rastogi P.

   ANCA glomerulonephritis post Moderna COVID-19 vaccination. Kidney Int 2021;100:473–4.

   OpenUrl
7. 7.↵
   1. Jennette JC,
   2. Falk RJ,
   3. Bacon PA, et al

   . 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1–11.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Ahmed S,
   2. Zimba O,
   3. Gasparyan AY.

   COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 2021; 40:2611–9.

   OpenUrlCrossRefPubMed